96. Crohn disease Clinical trials / Disease details

Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04682522 (ClinicalTrials.gov)	March 21, 2021	9/12/2020	Flagyl Microbiome in Crohn's Disease	Does the Microbiome Change With Flagyl Treatment After Ileocolic Resection for Crohn's Disease	Crohn Disease	Drug: Metronidazole Oral	University of Louisville	NULL	Recruiting	20 Years	80 Years	All	36	Phase 4	United States
2	EUCTR2011-000885-36-ES (EUCTR)	26/12/2011	29/11/2011	Adalimub treatment to prevent recurrency post-surgery in Crohn disease.	Multicentric, randomized double blind clinical trial and paralell groups to compare Adalimub vs Azatioprina efficacy prevention in Crhon disease post-surgical recurrency after 52 weeks of treatment - APPRECIA	Compare efficay of Adalimub vs Azatioprina to prevent surgical intervention in Chron disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]	Trade Name: Humira Product Name: Humira INN or Proposed INN: Adalimumab Other descriptive name: Adalimumab Trade Name: Imurel Product Name: Imurel INN or Proposed INN: Azatioprina Other descriptive name: Imurel Trade Name: Flagyl Product Name: Flagyl INN or Proposed INN: Metronidazol Other descriptive name: Flagyl	GETECCU	NULL	Not Recruiting			Female: yes Male: yes			Spain